<bill session="110" type="hr" number="681" updated="2013-07-19T20:56:26-04:00">
  <state datetime="2007-09-25">REFERRED</state>
  <status>
    <introduced datetime="2007-09-25"/>
  </status>
  <introduced datetime="2007-09-25"/>
  <titles>
    <title as="introduced" type="official">To express the sense of the House of Representatives regarding the Medicare national coverage determination on the treatment of anemia in cancer patients.</title>
  </titles>
  <sponsor id="412236"/>
  <cosponsors>
    <cosponsor id="400645" joined="2007-12-11"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2007-09-25">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2007-09-25">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2007-09-25">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2007-10-03">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Ways and Means"/>
    </action>
    <action datetime="2007-11-08">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Blood diseases"/>
    <term name="Cancer"/>
    <term name="Chemotherapy"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drugs"/>
    <term name="Government operations and politics"/>
    <term name="Law"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Social welfare"/>
  </subjects>
  <amendments/>
  <summary>9/25/2007--Introduced.
Expresses the sense of the House of Representatives that the Centers for Medicare and Medicaid Services should: (1) begin an immediate reconsideration of the final National Coverage Determination on the Use of Erythropoiesis Stimulating Agents in Cancer and Related Neoplastic Conditions; (2) consult with members of the clinical oncology community to determine appropriate revisions to such Determination; and (3) implement appropriate revisions to such Determination as soon as feasible and provide a briefing to Congress in advance of announcing such changes.</summary>
</bill>
